President Francisco Sagasti announced the agreement to purchase vaccines from the Sinopharm laboratory, whose first batch of one million vaccines would be arriving by the end of the month.
“The purchase is for 38 million doses of vaccines, and it is expected to have between 14 and 15 million Peruvians vaccinated,” he said in a statement as La República newspaper reported.
A purchase agreement has also been signed with AstraZeneca, and as of September the first doses of a total of 14 million will arrive.
In addition, there is an agreement for 13.2 million doses of Covax Facility. While the date is not yet known, it should start in the third quarter of 2021.
Sagasti explained that there are negotiations with laboratories with the US, Germany, Russia and India, and is following the Peruvian vaccine project developed by the Universidad Peruana Cayetano Heredia (UPCH) and the company Farvet.